Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Mylan Set To Lose $800M in EpiPen Sales

As rival epinephrine injectors catch up and drive prices down, EpiPen is on track to lose $800 million in sales by 2018.

EpiPen / Photo: FiercePharma
EpiPen / Photo: FiercePharma

A January 9th FiercePharma article says the aggressive price hikes on Mylan’s EpiPen could be coming back to haunt them. Bernstein analysts believe the injector is on track to do just $300 million in sales in 2018, down from an estimated $1.1 billion in 2016. Kaleo’s Auvi-Q is set to launch in the first half of 2017, and Adamis has re-filed its potential rival after an FDA rejection caused Teva to ditch the rights.

However, Mylan isn’t necessarily backing down; they launched an authorized generic at half the price last month. And as Bloomberg noted, Mylan is planning to offer EpiPens through its own pharmacy in an effort to eliminate the middlemen CEO Heather Bresch blames for the price increases. Mylan is also lobbying for “entity prescription” that would allow public places like restaurants and parks to purchase and store EpiPens.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO